3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Completed
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Plasma cell
2
Other
2
Classical hematology
2
Conditions
Multiple Myeloma
5
Mucositis
2
Febrile Neutropenia
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Smoldering Multiple Myeloma
1
Recurrence
1
Rectal Neoplasms
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Pancreatic Adenocarcinoma
1
Neurotoxicity Syndromes
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Neoplasm Metastasis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Hematologic Neoplasms
1
Cytokine Release Syndrome
1
Cryopyrin-Associated Periodic Syndromes
1
Colorectal Neoplasms
1
Breast Neoplasms
1
Interventions
pegylated granulocyte colony-stimulating factor
3
pegfilgrastim
3
Vancomycin
3
Interleukin 1 Receptor Antagonist Protein
2
Filgrastim
2
Ceftazidime
2
Cefepime
2
Amikacin
2
Vaccination
1
Teicoplanin
1
Tazobactam
1
Surveys and Questionnaires
1
Sodium Chloride
1
Positron Emission Tomography Computed Tomography
1
Pneumococcal Vaccines
1
Piperacillin
1
N,N'-bis(pyridoxal-5-phosphate)ethylenediamine-N,N'-diacetic acid
1
Meropenem
1
Linezolid
1
Itraconazole
1
Injections
1
Cloxacillin
1
Ciprofloxacin
1
Cilastatin, Imipenem Drug Combination
1
Bevacizumab
1
Anti-Bacterial Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Febrile Neutropenia
×
Interleukin 1 Receptor Antagonist Protein
×
Clear all
NCT03233776
2024-11-18
AFFECT-1
Radboud University Medical Center
Phase 2
Completed
9 enrolled
NCT04099901
2024-11-18
AFFECT-2
Radboud University Medical Center
Phase 2
Completed
88 enrolled